COMMUNIQUÉS West-GlobeNewswire

-
Arcutis to Present Two Posters at the 83rd American Academy of Dermatology Annual Meeting
28/02/2025 - 15:00 -
Novartis data presentations at AAAAI and AAD underscore commitment to advancing treatment of hidradenitis suppurativa (HS) and chronic spontaneous urticaria (CSU)
28/02/2025 - 15:00 -
Alumis Announces Late-Breaker Psoriasis Presentation of 52-week Phase 2 OLE Data for ESK-001 at 2025 American Academy of Dermatology Annual Meeting and Accelerated Topline Phase 3 Data Readout
28/02/2025 - 15:08 -
ORYZON Announces the Voting Results of February 2025 Extraordinary General Shareholders' Meeting
28/02/2025 - 15:14 -
Orion Corporation: Managers’ transactions – Niclas Lindstedt
28/02/2025 - 16:00 -
CORRECTION: Spectral AI Schedules 2024 Fourth Quarter and Full Year Financial Results and Conference Call
28/02/2025 - 16:34 -
SRx Health Solutions Granted Final Order to Proceed with the Acquisition by Better Choice Company
28/02/2025 - 16:41 -
Orion Corporation: Managers’ transactions – Outi Vaarala
28/02/2025 - 16:45 -
Bavarian Nordic Receives Marketing Authorization in Europe for Chikungunya Vaccine for Persons Aged 12 and Older
28/02/2025 - 17:14 -
Valneva reçoit un avis positif du CHMP de l’EMA pour élargir l’indication de son vaccin contre le chikungunya IXCHIQ® aux adolescents
28/02/2025 - 17:45 -
Valneva Receives EMA’s Positive CHMP Opinion for Adolescent Label Extension for Chikungunya Vaccine IXCHIQ®
28/02/2025 - 17:45 -
Groupe PAT : Hausse du Chiffre d’Affaires Combiné 2024
28/02/2025 - 18:30 -
Tevogen Bio Founder and CEO Dr. Ryan Saadi Named to 2025 NJBIZ Power 100, Celebrating Innovation and Leadership in Accessible T Cell Therapy
28/02/2025 - 19:17 -
Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
28/02/2025 - 22:00 -
Apogee Therapeutics to Host Conference Call to Report Interim Results from the Phase 1 Healthy Volunteer Trial for APG990 and Provide Combination Strategy Update on March 3, 2025
28/02/2025 - 22:00 -
Grant of Restricted Stock Units to Management and Employees and Grant of Warrants to Employees in Genmab
28/02/2025 - 22:00 -
Aclarion, Inc. Announces Adjournment of Special Meeting of Stockholders
28/02/2025 - 22:01 -
Longeveron® Announces Full-Year 2024 Financial Results and Provides Business Update
28/02/2025 - 22:04 -
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
28/02/2025 - 22:04
Pages